Synthesis and pharmacological characterization of UVI3502, a novel cannabinoid receptor 1 (CB1) antagonist/inverse agonist
I. Bengoetxea de Tena, G. Pereira-Castelo, J. Martinez-Gardeazabal, M. Moreno-Rodriguez, I. Manuel, C. Martinez, B. Vaz, J. Gonzalez-Ricarte, R. Alvarez, A. Torres-Mozas, F. Peccati, G. Jimenez Oses, A. Rodriguez De Lera, R. Rodriguez-Puertas
This paper synthesizes and characterizes UVI3502, a novel CB1 receptor antagonist/inverse agonist, showing high affinity for CB1 and low affinity for CB2, with potential interactions with GPR55.
bioRxiv · Jun 14, 2024 · PreprintPharmacology & Toxicology